Guide to Inhaled Treatment Choices
|
|
- Geraldine Brianna Walton
- 5 years ago
- Views:
Transcription
1 Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint formulary). Device Dose Counter Dose Check MDI - Visual Consider if low inspiratory flow. Always use with spacer device. Easy to use, consider Haleraid to help grip and press the canister if dexterity problems. Device Dose Counter Dose Check Respimat + Dose pointer enters the red area of the scale (7 days remaining) Visual Used in COPD only Requires priming before use. Easy to use, requires dexterity to prime device. Consider if low inspiratory flow. Dry Powder inhalers (DPI) Device Dose Counter Dose Check Note: all DPIs require sufficient inspiratory flow Accuhaler + Dose indicator with last 5 doses. Genuair + Dose indicator counts down in intervals of 10 (last 10 red). Visual/ Lactose taste Audible/ Visual/ Lactose taste NEXThaler + Audible/ Visual/ Lactose taste Turbohaler + Visual/ Lactose Cog-wheel dose indicator taste with last 20 doses marked in red. Pre-loaded, primed by opening Easy to use, requires minimal dexterity to prime. Used in COPD only Pre-loaded, primed by pressing button (coloured control window moves from red to green). Easy to use, required minimal dexterity. Requires sufficient inspiratory flow (coloured control window moves from green to red on inhalation). Pre-loaded, primed by opening. Easy to use, requires minimal dexterity. Pre-loaded, primed by twisting. Easy to use, consider Turbohaler Turning Aid if poor dexterity. Breezhaler - Capsule vibration Load each time with separate capsule, must pierce capsule. Required dexterity to load device. Advise patient not to swallow capsule. Zonda - Capsule vibration Used in COPD only Load each time with separate capsule, must pierce capsule. Required dexterity to load device. Capsule should be placed in centre chamber, NOT in mouthpiece. Advise patient not to swallow capsule. Information obtained from Mims for nurses: Respiratory devices Visual Guide, guide to Breath-Actuated Inhaler Full guidance available at mims.co.uk KEY MDI = Metered dose inhaler DPI = Dry Powder Inhaler + Yes - No
2 SABA-Short Acting Beta 2 Agonist Inhalers Salbutamol CFC Free 100 micrograms / 1.50 / 200 doses FIRST LINE for COPD and Asthma effective salbutamol MDI inhaler Salbutamol Autohaler 100 micrograms / 6.30 / 200 doses Should be reserved for use in patients that have difficulty synchronising aerosol actuation with inspiration of breath Salbutamol Easi-Breathe 100 micrograms / 6.30 / 200 doses Should be reserved for use in patients that have difficulty synchronising aerosol actuation with inspiration of breath 3.60 / 60 doses Salbutamol Accuhaler 200 micrograms / dose (DPI) Bricanyl Turbuhaler Terbutaline 500 micrograms / dose (DPI) 8.30 / 100 doses
3 LABA-Long Acting Beta2 Agonist Inhalers Serevent Salmeterol 25 micrograms / / 120 doses. Licensed age 4+. Serevent Accuhaler Salmeterol 50 micrograms / dose (DPI) / 60 doses Formoterol Easyhaler 12micrograms / dose (DPI) / 120 doses Licensed 6+. Oxis Turbohaler Formoterol 6 micrograms / dose (DPI) / 60 doses Oxis Turbohaler Formoterol 12micrograms / dose (DPI) / 60 doses
4 SAMA-Short Acting Muscarinic Antagonist Inhalers Atrovent Ipratropium bromide 20 micrograms / 5.56 / 200 doses. Prescribe by Atrovent brand as this is the only brand that can be used with a spacer device LAMA-Long Acting Muscarinic Antagonist Inhalers Eklira Genuair Aclidinium 400micrograms / dose (DPI) (delivers 322 micrograms of aclidinium) / 60 doses Licensed for COPD only. Alternative to tiotropium. Less published evidence but device may be easier to use for those with dexterity issues. Braltus Zonda Inhaler Tiotropium 10micrograms / dose (DPI) / 30 doses FIRST Line in COPD for new and existing patients Licensed for COPD only. The Braltus Zonda and Spiriva Handihaler deliver the same dose (10mcg). Capsule should be placed in centre chamber, NOT in mouthpiece. Spiriva Handihaler Tiotropium 18 micrograms / dose (DPI) Handihaler device + capsules / 30 doses Refill capsules / 30 doses Licensed for COPD only. Second line choice brand for DPI tiotropium inhaler for new and existing patients. (The Braltus Zonda and Spiriva Handihaler deliver the same dose (10mcg).) Spiriva Respimat Tiotropium 2.5micrograms / 23 / 60 doses Locally approved for COPD only although licensed for COPD and asthma.
5 ICS-INHALED CORTICOSTEROID INHALERS Clenil Modulite CFC Free Beclometasone 50 micrograms / 3.70 / 200 doses Prescribe by brand name Clenil Modulite.. Clenil Modulite CFC Free Beclometasone 100 micrograms / 7.42 / 200 doses Prescribe by brand name Clenil Modulite.. Clenil Modulite CFC Free Beclometasone 200 micrograms / / 200 doses Prescribe by brand name Clenil Modulite.. Clenil Modulite CFC Free Beclometasone 250 micrograms / / 200 doses Prescribe by brand name Clenil Modulite.. Qvar CFC-FREE Beclometasone 50 micrograms / 7.87 / 200 doses Prescribe by brand name Qvar. (Can only be used with the AeroChamber Plus spacer device)
6 ICS-INHALED CORTICOSTEROID INHALERS continued Qvar CFC-FREE Beclometasone 100 micrograms / / 200 doses Prescribe by brand name Qvar. (Can only be used with the AeroChamber Plus spacer device) Beclometasone Easibreathe 50 micrograms / 7.74 / 200 doses Beclometasone Easibreathe 100 micrograms / / 200 doses Budesonide Easyhaler 100 micrograms / dose (DPI) 8.86 / 200 doses Budesonide Easyhaler 200 micrograms / dose (DPI) / 200 doses
7 ICS-INHALED CORTICOSTEROID INHALERS continued Budesonide Easyhaler 400 micrograms / dose (DPI) / 100 doses Pulmicort Turbohaler Budesonide 100 micrograms / dose (DPI) / 200 doses Pulmicort Turbohaler Budesonide 200 micrograms / dose (DPI) / 100 doses Pulmicort Turbohaler Budesonide 400 micrograms / dose (DPI) / 50 doses Flixotide CFC free inhaler Fluticasone 50 micrograms / 5.44 / 120 doses.
8 ICS-INHALED CORTICOSTEROID INHALERS continued Flixotide CFC free MDI inhaler Fluticasone 125 micrograms / / 120 doses. Flixotide CFC free MDI inhaler Fluticasone 250 micrograms / / 120 doses. Flixotide Accuhaler Fluticasone 50 micrograms / dose (DPI) 4.00 / 60 doses Flixotide Accuhaler Fluticasone 100 micrograms / dose (DPI) 8.00 / 60 doses Flixotide Accuhaler Fluticasone 250 micrograms / dose (DPI) / 60 doses
9 ICS-INHALED CORTICOSTEROID INHALERS continued Flixotide Accuhaler Fluticasone 500 micrograms / dose (DPI) / 60 doses LABA/ICS COMBINATION INHALERS Fostair 100 / 6, beclometasone 100 micrograms and formoterol 6 micrograms / / 120 doses FIRST line in COPD Prescribe by brand name Fostair Contains a small amount of ethanol Fostair 200 / 6 beclometasone 200 mcgs and formoterol 6 mcgs / / 120 doses Prescribe by brand name Fostair Contains a small amount of ethanol Fostair NEXThaler 100 / 6, beclometasone 100 micrograms and formoterol 6 micrograms / dose (DPI) / 120 doses Prescribe by brand name Fostair Nexthaler. Fostair NEXThaler 200 / 6, beclometasone 200 micrograms and formoterol 6 micrograms / dose (DPI) / 120 doses Prescribe by brand name Fostair Nexthaler.
10 LABA/ICS COMBINATION INHALERS continued DuoResp Spiromax 160 / 4.5, budesonide 160 micrograms and formoterol 4.5 micrograms / / 120 doses Prescribe by brand name Duoresp Spiromax effective inhaler combination of budesonide and formoterol. DuoResp Spiromax 320 / 9, budesonide 320 micrograms and formoterol 9 micrograms / / 120 doses Prescribe by brand name Duoresp Spiromax effective inhaler combination of budesonide and formoterol. Symbicort Turbohaler 100 / 6, budesonide 100 micrograms and formoterol 6 micrograms / dose (DPI) / 120 doses Prescribe by brand name Symbicort Turbohaler Symbicort Turbohaler 200 / 6, budesonide 200 micrograms and formoterol 6 micrograms / dose (DPI) / 120 doses Prescribe by brand name Symbicort Turbohaler Symbicort Turbohaler 400 / 12, budesonide 400 micrograms and formoterol 12 micrograms/dose (DPI) / 60 doses Prescribe by brand name Symbicort Turbohaler
11 LABA/ICS COMBINATION INHALERS continued Airflusal Fospiro 500 / 50 fluticasone 500 micrograms and salmeterol 50 micrograms / dose (DPI) / 60 dose Prescribe by brand name Airflusal Licensed for COPD only Seretide Accuhaler 100 / 50 fluticasone 100 micrograms and salmeterol 50 micrograms / dose (DPI) / 60 doses Prescribe by brand name Seretide Accuhaler Seretide Accuhaler 250 / 50 fluticasone 250 micrograms and salmeterol 50 micrograms / dose (DPI) / 60 doses Prescribe by brand name Seretide Accuhaler Seretide Accuhaler 500 / 50 fluticasone 500 micrograms and salmeterol 50 micrograms / dose (DPI) / 60 doses Prescribe by brand name Seretide Accuhaler
12 LABA/ICS COMBINATION INHALERS continued Airflusal MDI 125 / 25 fluticasone 125 micrograms and salmeterol 25 micrograms / / 120 dose Prescribe by brand name Airflusal Airflusal MDI 250 / 25 fluticasone 250 micrograms and salmeterol 25 micrograms / / 120 dose Prescribe by brand name Airflusal Sirdupla 125/25 fluticasone 125 micrograms and salmeterol 25 micrograms / / 120 doses Prescribe by brand name Sirdupla Sirdupla 250 / 25 fluticasone 250 micrograms and salmeterol 25 micrograms / / 120 doses Prescribe by brand name Sirdupla Seretide Evohaler 50 / 25 fluticasone 50 micrograms and salmeterol 25 micrograms / dose (MDI) / 120 doses Prescribe by brand name Seretide Evohaler
13 LABA/ICS COMBINATION INHALERS continued Seretide Evohaler 125 / 25 fluticasone 125 micrograms and salmeterol 25 micrograms / / 120 doses Prescribe by brand name Seretide Evohaler Seretide Evohaler 250 / 25 fluticasone 250 micrograms and salmeterol 25 micrograms / / 120 doses Prescribe by brand name Seretide Evohaler LABA/LAMA COMBINATION INHALERS Duaklir Genuair aclidinium 400 micrograms (as bromide 340 micrograms), formoterol (as fumarate dihydrate) 12 micrograms (DPI) 32.50/ 60 doses Prescribe by brand name Duaklir Genuair Licensed for COPD only Spiolto Respimat tiotropium (as bromide monohydrate) 2.5 micrograms, olodaterol (as hydrochloride) 2.5micrograms (MDI) 32.50/ 60 doses FIRST Line in COPD Prescribe by brand name Spiolto Respimat Licensed for COPD only Ultibro Breezhaler glycopyrronium bromide 43 micrograms and indacaterol malete 85micrograms / dose (DPI) / 30 doses Prescribe by brand name Ultibro Breezhaler Licensed for COPD only Severe renal impairment or end stage renal dialysis only use if the expected benefit outweighs the risk
14 SPACER DEVICES Able Spacer (Clement Clarke) 4.39 Small-volume device. For use with all pressurised (aerosol) inhalers, with infant or child mask AeroChamber Plus (GSK) 4.90 (With mask 8.17) Medium-volume device. For use with all pressurised (aerosol) inhalers. Standard device (blue), infant device (orange) with mask, child device (yellow) with mask. Volumatic (A&H) 3.88 Large-volume device. For use with Clenil Modulite, Flixotide, Seretide, Serevent and Salbutamol MDI inhalers
15 Links to Inhaler Training Videos Accuhaler: Metered Dose Inhaler: Metered Dose Inhaler & Volumatic spacer device: Metered Dose Inhaler & AeroChamber Plus spacer device: Autohaler: Breezhaler Inhaler: Easi-Breathe Inhaler: Easyhaler Inhaler: Fospiro Inhaler: Genuair Inhaler: Spiriva Handihaler Inhaler: NEXThaler Inhaler: Respimat Inhaler: Spiromax Inhaler: Turbohaler Inhaler:
16
Guide to Inhaled Treatment Choices
Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint
More informationRespiratory Inhalers. Identification Guide Version 3
Respiratory Inhalers Identification Guide Version 3 This booklet has been prepared by NHSGGC Medicines Information. Endorsed by NHSGGC Respiratory Managed Clinical Network, February 2017. Designed by Medical
More informationWirral COPD Prescribing Guidelines
Wirral COPD Prescribing Guidelines (To be read in conjunction with the Wirral COPD Supplementary Information) STEP 1: Assess symptoms COPD Assessment Test (CAT) [Link for CAT-test Online] is a patient-completed
More informationNHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group
NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group Inhaler technique and respiratory conditions Guidance Sheet 16 When diagnosed
More informationPocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals
Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Endorsed by NHSGGC Respiratory Managed Clinical Network; June 2016 Designed by Medical Illustration Services Contents
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES Document Description Document Type Service Application Version Guidelines All healthcare professionals(hcps) caring for patients with asthma
More informationPrescribing guidelines: Management of COPD in Primary Care
Prescribing guidelines: Management of COPD in Primary Care Establish diagnosis of COPD in patients 35 years with appropriate symptoms with history, examination and spirometry (FEV1/FVC ratio < 70%) Establish
More informationGMMMG Asthma Formulary Inhaler Options August 2017
Regular Preventer Beclometasone Beclometasone Beclometasone Brand name Qvar Easi-Breathe Clenil Modulite Easyhaler Device MDI MDI DPI Strengths 50 microgram 100 microgram 200 microgram Adult asthma 2 inhalations
More informationGMMMG COPD Formulary Inhaler Options October 2017
BNF 3.1.1 Adrenocepter agonists (SABA) Salbutamol Salbutamol Terbutaline Brand name Airsalb Ventolin Evohaler Bricanyl Turbohaler Device MDI MDI Dry powder Strengths 100 microgram 100 microgram 500 microgram
More informationCOPD Inhaled Therapy Prescribing Guidance
COPD Inhaled Therapy Prescribing Guidance For Basingstoke, Southampton and Winchester District Prescribing Committee This guidance applies to patients with a COPD DIAGNOSIS CONFIRMED BY POSTBRONCHODILATOR
More informationNHS Dumfries & Galloway Triple therapy in COPD patients over 16 years
Title of Project: NHS Dumfries & Galloway Triple therapy in COPD patients over 16 years 1 Reason for the review Respiratory prescribing is long term and can be costly. Appropriate choice and use of inhaled
More informationPosition within the Organisation
ASTHMA TREATMENT GUIDELINES Document Description Document Type Service Application Guidelines All healthcare professionals(hcps) caring for patients with asthma Version 4.0 Ratification date September
More informationCo. Durham & Darlington Respiratory Network COPD Treatment Guide
Co. Durham & Darlington Respiratory Network COPD Treatment Guide Age > 35, Productive cough, Breathless, Smoking Hx Spirometry (post-bronchodilator) COPD Advice Intensive smoking cessation support Vaccination
More informationASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12
North Hampshire CCG Asthma Prescribing Guidelines June 2015 ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12 These guidelines are based on the British Thoracic Society (BTS) and Scottish Intercollegiate
More informationCOPD Inhaled Therapy Prescribing Guidance
COPD Inhaled Therapy Prescribing Guidance For Basingstoke, Southampton and Winchester District Prescribing Committee This guidance applies to patients with a COPD DIAGNOSIS CONFIRMED BY POSTBRONCHODILATOR
More informationINHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop
INHALERS for COPD Dr Christopher Worsnop Department of Respiratory Medicine Austin Hospital INTRODUCTION Most drugs for COPD are given via inhalers. This reduces the dose that needs to be given and delivers
More informationCHARM Guidelines for the diagnosis and
\ CHARM Guidelines for the diagnosis and management of COPD City and Hackney CCG Homerton University Hospital NHS Foundation Trust Written by: Miss Hetal Dhruve, Specialist Pharmacist Respiratory Medicine,
More informationDose. Route. Units. Given. Dose. Route. Units. Given
Chapter 4 Respiratory Andrew Stanton SALBUTAMOL (in acute asthma) 5 in acute asthma Nebulised (driven by oxygen not air) 4 6 hourly In acute severe asthma not responding to initial treatment or in life-threatening
More informationTHE COPD PRESCRIBING TOOL
THE COPD PRESCRIBING TOOL Revised edition, 2017 www.bpac.org.nz/copd CLASSIFICATION The COPD prescribing tool This tool provides pharmacological treatment options for patients with COPD based on their
More informationCOPD RESOURCE PACK Section 5. Drug Treatment & Inhalers in Stable COPD
COPD RESOURCE PACK Section 5 Drug Treatment & Inhalers in Stable COPD In this section: 1. Links to Fife Formulary 2. Pharmacological Management of Stable COPD 3. How to use a Metered Dose Inhaler 4. How
More informationRESPIRATORY INHALERS
RESPIRATORY INHALERS The correct administration of inhaled therapy is essential for successful, cost-effective and safe therapy. Everyone, including the patient needs to understand the importance of ensuring
More informationMedicines Management Programme Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD)
Medicines Management Programme Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD) Approved by Prof. Michael Barry, Clinical Lead, MMP. Date approved Version 1 July 2014 Date updated Version
More informationMedicines Management of Chronic Obstructive Pulmonary Disease (COPD)
Medicines Management of Chronic Obstructive Pulmonary Disease (COPD) (Chronic & Acute) Guidelines for Primary Care Guideline Authors: Shaneez Dhanji (Wandsworth CCG) Samantha Prigmore (St George s Hospital)
More informationReport generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Section.
Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACLIDINIUM BROMIDE bronchodilators ADRENALINE/EPINEPHRINE
More informationChapter 3: Respiratory System (7 th Edition)
Chapter 3: Respiratory System (7 th Edition) The Sheffield respiratory guidelines (April 2015) have been removed from the intranet. This is because the COPD section has been superseded by the COPD treatment
More informationStepping-down combination ICS/LABA asthma inhaler therapy: Adults 18yrs
Step Down guidance Stepping-down combination ICS/LABA asthma inhaler therapy: Adults 18yrs Important Complete asthma control needs to be achieved for at least 12 weeks before attempting to step patients
More informationCOPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes
COPD Medications Coverage Summary Drug Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes Ventolin MDI + generics Yes Yes Ventolin Diskus NO NO Yukon Pharmacare/Chronic Disease Program
More informationAdult Summary flowchart for Asthma Switch and Step Down to preferred inhaler choices
HVCCG Adult Asthma Switch and Step Down Algorithms - Approved by Hertfordshire Medicines Management Committee June 2016 Page 1 of 6 Adult Summary flowchart for Asthma Switch and Step Down to preferred
More informationWhy Asthma Still Kills The National Review of Asthma Deaths (NRAD)
APPROVED FINAL VERSION NHS Protect Why Asthma Still Kills The National Review of Asthma Deaths (NRAD) Summary of Recommendations for GP Practices and Community Pharmacies Author: Anne Henry Contact: anne.henry@nhs.net
More informationSABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA
COPD GUIDELINES DIAGNOSIS >35 years of age Symptoms of cough, breathlessness, sputum, wheeze, Risk factor (SMOKING) Spirometry (post bronchodilator) FEV1/FVC = 0.7 ENCOURAGE PATIENTS TO BRING INHALERS
More informationAdult Summary flowchart for Asthma Switch and Step Down to ENHCCG preferred inhaler choices
ENHCCG Adult Asthma Switch and Step Down Algorithms - Approved by Hertfordshire Medicines Management Committee June 2016 Page 1 of 6 Adult Summary flowchart for Asthma Switch and Step Down to ENHCCG preferred
More informationAsthma Treatment Guideline for Adults (aged 17 and over)
Asthma Treatment Guideline for Adults (aged 17 and over) Sharon Andrew MLCSU January 2019 (Review date 0 January 2022) VERSION CONTROL. Please access via the LMMG website to ensure that the correct version
More informationInclude patients: with a confirmed diagnosis of asthma who have been free of asthma symptoms for 3 months or more.
Corby Clinical Commissioning Group Kettering General Hospital NHS Trust Nene Clinical Commissioning Group rthampton General Hospital NHS Trust rthamptonshire Healthcare Foundation Trust Stepping down asthma
More informationGreater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma
Greater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma Non-pharmacological options for ALL patients, consider at ALL stages Make sure diagnosis
More informationAddress Comorbidities
Greater Manchester COPD Management Plan Non-pharmacological management for ALL patients Smoking Cessation Annual Flu Vaccination Pulmonary Rehabilitation Increase daily activity Inhaler Technique Measure
More informationRespiratory Inhaler Check-up Service
Respiratory Inhaler Check-up Service Dr Toby Capstick Lead Respiratory Pharmacist Leeds Teaching Hospitals NHS Trust toby.capstick@nhs.net 8 th May 2018 What is the Challenge? The Burden of Disease in
More informationWhat is the Challenge?
Respiratory Inhaler Check-up Service What is the Challenge? Dr Toby Capstick Lead Respiratory Pharmacist Leeds Teaching Hospitals NHS Trust toby.capstick@nhs.net 25 th September 2018 The Burden of Disease
More informationChronic Obstructive Pulmonary Disease (COPD) Primary Care Guideline
Chronic Obstructive Pulmonary Disease (COPD) Primary Care Guideline For use across all Norfolk & Waveney CCGs Based on GOLD 2017 1, NICE CG101 COPD 2. Norfolk & Waveney Group In the UK in 2012, 29,776
More informationStepping down asthma treatment guidelines
Stepping down asthma treatment guidelines The potential for inhaled corticosteroids (ICS) to cause dose-related side-effects has led to asthma management guidelines recommending a dose reduction once asthma
More informationIf you require this document in another format such as Braille, large print, audio or another language please contact the Trusts Communications Team
MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ADULTS Summary statement: How does the document support patient care? Staff/stakeholders involved in development: Job titles only Division:
More informationAlgorithm for the use of inhaled therapies in COPD Version 2 May 2017
Algorithm for the use of inhaled therapies in COPD This document has been revised by the Berkshire West Respiratory Network to support clinicians in selecting the most appropriate, cost effective treatments
More informationPlease also see section on Drugs used in substance dependence for patients with established chemical dependence
Respiratory System Algorithm for the selection of the most appropriate inhaler device for patients with chronic stable asthma Information on Inhaler devices Devices β 2 agonist bronchodilators Antimuscarinic
More information3. Respiratory System
1 3. Respiratory System Also see Appendix 3A Guidance on Management of Also see Appendix 3B Preferred Inhaler Devices for Adults Also see Appendix 3C Preferred Inhaler Devices for Adolescents (12-18 years)
More informationProgress, Paediatrics and Protocols. Dr Andy Powell Dr Lesley Ayling West Hampshire CCG
Progress, Paediatrics and Protocols Dr Andy Powell Dr Lesley Ayling West Hampshire CCG Progress Solutions CQUIN discharge bundle (including personal action plan), specialist review, immediate management
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE Bulletin 218: September 2015 Review Date: September 2018 LAMA / LABA combination inhalers in COPD- Place in therapy review and choice of therapy JPC Recommendations:
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE December 2014 Review Date: December 2017 Bulletin 206 : DuoResp Spiromax 160 / 4.5 and 320 / 9 budesonide & formoterol dry powder inhaler JPC Recommendations
More informationSummary of Lothian Joint Formulary Amendments
Summary of Lothian Joint Formulary Amendments The purpose of this summary is to detail the main changes to the LJF sections and provide additional information on the reasons for some of the changes. The
More informationCHARM ASTHMA TREATMENT GUIDELINE
NHS City and Hackney Prescribing Guidelines Adults ( 12 years of age) CHARM ASTHMA TREATMENT GUIDELINE Written by: Hetal Dhruve (Specialist Respiratory Pharmacist, City and Hackney CCG) Checked by: Prof
More informationBREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)
Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed
More informationBREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)
Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed
More informationBREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)
Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE September 2015 Review Date: September 2018 Bulletin 219: Choice of Long Acting Muscarinic Agent (LAMA) inhaler for COPD JPC Recommendation: The availability
More informationCOPD Prescribing Guidelines
Cannock Chase Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group East Staffordshire Clinical Commissioning
More informationRESPIRATORY PRESCRIBING SCHEMES GUIDE 2017/18
impact500 www.ccgprescriber.org RESPIRATORY PRESCRIBING SCHEMES GUIDE 2017/18 TOTAL AVAILABLE NHS SAVINGS IN THIS EDITION 133 MILLION EDITION TWO Analysis was undertaken using May 2017 tariff and February
More informationAlgorithm for the use of inhaled therapies in COPD
Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire Healthcare NHS Foundation Trust Berkshire West Primary Care
More informationTHEOPHYLLINE WITH INHALED CORTICOSTEROIDS (TWICS) TRIAL SELF MANAGMENT / ACTION PLANS GENUAIR INHALERS: POTENTIAL SAFETY ISSUE
I S S U E 4 M A R C H / A R P I L 2 0 1 6 Endorsed December 2014 I N S I D E T H I S I S S U E : Theophylline with Inhaled Corticosteroids (TWICS) Trial Genuair Inhaler: Potential Safety Issue 1 Self Management
More informationHe is still Short of Breath Is there any new puffer? Saidul Ansary
He is still Short of Breath Is there any new puffer? Saidul Ansary Mr S C 66 yr. old retired Engineer for pre op elective assessment I am fine but Anaesthetist said I need to see you. I am little bit SOB,
More informationBNF CHAPTER 3: RESPIRATORY
3.1 BRONCHODILATORS BNF CHAPTER 3: RESPIRATORY 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated (e.g., Easi-Breathe
More informationChronic Obstructive Pulmonary Disease (COPD) Management
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Chronic Obstructive Pulmonary Disease (COPD) Management Diagnosis of COPD should be considered in patients over the age of 35 who have a risk factor (generally
More informationRespiratory Health. Asthma and COPD
Respiratory Health Asthma and COPD Definition of asthma Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation in lung function Large variation in respiratory
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE December 2014 Review date: December 2017 Bulletin 208 : Indacaterol + Glycopyrronium bromide 85/43 micrograms (Ultibro Breezhaler ) for the Treatment
More informationInhalers containing CFCs. CFC-free inhalers
Propellants used in medical metered dose inhalers and aerosol-based breath activated devices in New Zealand August to October 2002 (most recent period for which data is available) (February 2003) Inhalers
More informationInhalation devices, proper technique and cleaning
Preventing Your Symptoms and Taking Your Medications Inhalation devices, proper technique and cleaning Knowing how to use your medications properly is important because inhaled drugs are meant to get directly
More informationMedicines Management of Asthma
Wandsworth Borough Team Medicines Management of Guidelines for Primary Care September 2011 Version 1 Guideline Authors: Shaneez Dhanji (Wandsworth borough) Reena Rabheru-Dodhy (Sutton & Merton borough)
More informationFerris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS
Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS Objectives Categorize the new asthma and COPD inhalers in to existing or newly created categories Discuss the
More informationA multitude of devices
A multitude of devices Dr Andrew Scroop Respiratory Consultants 15 th September 2018 STEPWISE PHARMACOLOGICAL MANAGEMENT OF STABLE COPD COPD Inhalers MILD FEV 1 60 80% predicted few symptoms breathless
More informationASTHMA TREATMENT GUIDE (ADULTS)
ASTHMA TREATMENT GUIDE (ADULTS) The BTS/SIGN guideline provides a wide range of information and guidance on the treatment of patients with asthma. https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016/
More informationCOPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy
Update: Focus on Intensifying LABA, LAMA and ICS Therapy B.C. Provincial Academic Detailing Service February 2017 Background In Canada, approximately 20 inhaled medications are approved to treat Chronic
More informationEvidence Review for Prescribing Clinical Network
Summary page Evidence Review for Prescribing Clinical Network Treatment: LABA/LAMA Combination devices in COPD Anoro Ellipta, Ultibro and Duaklir Genuair Prepared by: Noreen Devanney Topic Submitted by:
More informationMetered Dose Inhaler (MDI)
Metered Dose Inhaler (MDI) If the inhaler has not been used before, a test dose should be fired into the air to prime the system. 1. Remove cap. 2. Shake well. 3. Breathe out fully. 4. Holding inhaler
More informationChoosing an inhaler for COPD made simple. Dr Simon Hart Castle Hill Hospital
Choosing an inhaler for COPD made simple Dr Simon Hart Castle Hill Hospital 1 Declaration of interests I have received speaker fees, sponsorship to attend conferences, and funding for research from companies
More information500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device
3.1 BRONCHODILATORS 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol Terbutaline 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated e.g. Easi-Breathe 200 micrograms/dose
More informationBetter Living with Obstructive Pulmonary Disease A Patient Guide
Better Living with Obstructive Pulmonary Disease A Patient Guide Second Edition November 2012 Queensland Health a Better Living with Chronic Obstructive Pulmonary Disease A Patient Guide is a joint project
More informationInhaler technique for people with asthma or COPD
INFORMATION PAPER INHALER FOR HEALTH TECHNIQUE PROFESSIONALS FOR PEOPLE WITH ASTHMA OR COPD INHALER TECHNIQUE FOR PEOPLE WITH ASTHMA OR COPD Inhaler technique for people with asthma or COPD UPDATED KEY
More informationLong-acting bronchodilators: their properties and place in treatment
Long-acting bronchodilators: their properties and place in treatment Steve Chaplin MSc, MRPharmS and Paul Walker BMedSci (Hons), MD, FRCP Steve Chaplin and Dr Paul KEY POINTS Walker provide an overview
More informationThese lung function tests involve you being seated and breathing into specialist equipment (like that shown below), via a filter and a mouthpiece.
Lung Function Tests This leaflet only gives you general information about the lung function (breathing) tests. However, it does not replace the need for the personal advice from the health care professional.
More informationCOPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator
Medicine. No one ever showed me how to use this. Wendy Happel; RRT, Educator Krystal Fedoris; RRT-NPS, BA, Educator 1 Taking prescriptions correctly Taking prescriptions can be a challenge Busy schedules
More informationChronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines
Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines Where appropriate the following should be offered before commencing inhaled treatment: Offer treatment and support to stop smoking. Smoking
More informationDelivering Aerosol Medication in ICU
Delivering Aerosol Medication in ICU 18th Aug 2017 Lau Chee Lan Pharmacist HCTM PPUKM ASMIC 2017 Aerosol Therapy Part of the treatment for a variety of respiratory disease * asthma and chronic obstructive
More informationCOPD The New Epidemic. Peter Lin MD CCFP Director Primary Care Initiatives Canadian Heart Research Centre
COPD The New Epidemic Peter Lin MD CCFP Director Primary Care Initiatives Canadian Heart Research Centre Conflict Disclosure Information Speaker: Dr. Peter Lin Title of Talk: COPD The New Epidemic Financial
More informationReport generated from BNF with QVH Formulary provided by FormularyComplete ( Accessed Formulary Status.
Report generated from BNF with QVH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 09 10 2015 Title Formulary Status Section TA Number TA Link Annotation A2A Spacer Able Spacer Accolate
More informationInhaler technique reminder cards
Inhaler technique reminder cards Produced by the Medicines Optimisation Team NHS NEW Devon CCG For further information visit: www.newdevonccg.nhs.uk/information-for-patients/medicines-and-treatments/100073
More informationTRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationModule Two: Managing Your Medicine and Symptoms. Copyright All rights reserved. Powered by Mediasphere.
Module Two: Managing Your Medicine and Symptoms Copyright 2017. All rights reserved. Powered by Mediasphere. Welcome Welcome to Module Two of Lung Foundation Australia s C.O.P.E program. C.O.P.E. stands
More informationOutline. EPIC Project. February EPIC Project. Diagnosis: Spirometry. Differentiation between COPD & Asthma
EPIC Project Enabling Patient health Improvements though COPD medicines optimisation Dr Toby Capstick Toby.capstick@nhs.net Outline Background on COPD COPD Assessment Cost Effective Treatment Medication
More informationDiagnosis and management of Asthma in Adults. (Version 1.1)
Pan-Birmingham Respiratory Clinical Network Diagnosis and management of Asthma in Adults (Version 1.1) Revision History Guideline Author: Guideline Sponsor: Date of Approval: 23/03/2017 Approved by: Date
More informationCommon Drug Review Pharmacoeconomic Review Report
Common Drug Review Pharmacoeconomic Review Report January 2018 Drug umeclidinium bromide (Incruse Ellipta) Indication Listing request Dosage form(s) Manufacturer Indicated for long-term, once daily maintenance
More informationAPPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe
APPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe Instructions: Print on 8.5 x14 (216 x 279 mm) paper (Legal size) Medication in Green Zone Change
More informationbeclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite))
Case 1 Mr Thomson, a 32 year old asthmatic who is well known to you comes into your pharmacy. He is known to have a best peak flow of 640 L/min. He tells you that over the last few weeks he has been wakening
More informationMDI Bonanza. Dwayne Griffin, DO
MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing
More informationaclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A.
aclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A. 05 October 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and
More informationThe Medical Letter. on Drugs and Therapeutics
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More informationWhat you need to know about inhalers and how to use them Henry Chrystyn PhD, FRPharmS and David Price MA, MRCGP, DRCOG
What you need to know about inhalers and how to use them Henry Chrystyn PhD, FRPharmS and David Price MA, MRCGP, DRCOG VM The authors describe the problems that arise with metered-dose and dry-powder inhalers,
More informationMedicines Optimisation Team Standard Operating Procedure for Audit: High Dose Inhaled Corticosteroids
Cannock Chase Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group East Staffordshire Clinical Commissioning
More informationCOPD Device Workshop. Summary. Role of inhaler device in COPD. Why use inhaler device in COPD?
Part 1 Role of inhaler device in COPD COPD Device Workshop Dr Philip Lee Respiratory and Sleep Physician St George Hospital, Sydney Part 2 Part 3 Part 4 Incorrect inhaler technique-adverse clinical outcomes
More informationMedicines Management of Chronic Obstructive Pulmonary Disorder (COPD)
Medicines Management of Chronic Obstructive Pulmonary Disorder (COPD) Guidelines for Primary Care Guideline Authors: Shaneez Dhanji (NHS Wandsworth) and Reena Rabheru-Dodhy (NHS Sutton & Merton) Date Prepared:
More informationSupplementary materials
Supplementary materials Table S1 Patient comorbidities by diagnosis Total Asthma n (%) 5348 (148.4) COPD n (%) 4563 (143.4) ACOS n (%) 469 (197.9) No other comorbidities 95 (26.4) 614 (19.3) 27 (11.4)
More informationWhy should I read this booklet?
COPD The basics Why should I read this booklet? This booklet contains information for people who have recently been told by their doctor that they have a condition called Chronic Obstructive Pulmonary
More information